Precision Biosciences Inc [NASDAQ: DTIL] slipped around 129595.43 points on Wednesday, while shares priced at $129600.0 at the close of the session, down -7.22%.
Precision Biosciences Inc stock is now -54.89% down from its year-to-date (YTD) trading value. DTIL Stock saw the intraday high of $4.97 and lowest of $4.0605 per share. The company’s 52-week high price is 11.09, which means current price is +4.95% above from all time high which was touched on 01/10/25.
Compared to the average trading volume of 129.60K shares, DTIL reached a trading volume of 8204776 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Precision Biosciences Inc [DTIL]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DTIL shares is $30.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DTIL stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BMO Capital Markets have made an estimate for Precision Biosciences Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on April 30, 2024, representing the official price target for Precision Biosciences Inc stock. Previously, the target price had yet another raise to $7, while BMO Capital Markets analysts kept a Outperform rating on DTIL stock.
The Price to Book ratio for the last quarter was 0.91, with the Price to Cash per share for the same quarter was set at 6.96.
How has DTIL stock performed recently?
Precision Biosciences Inc [DTIL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.47. With this latest performance, DTIL shares dropped by -7.42% in over the last four-week period, additionally sinking by -7.83% over the last 6 months – not to mention a rise of 11.29% in the past year of trading.
Precision Biosciences Inc [DTIL]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Precision Biosciences Inc [DTIL] shares currently have an operating margin of -86.21% and a Gross Margin at 92.46%. Precision Biosciences Inc’s Net Margin is presently recorded at -42.99%.
Return on Equity for this stock declined to -14.22%, with Return on Assets sitting at -14.22%.
Insider trade positions for Precision Biosciences Inc [DTIL]
There are presently around $43.37%, or 48.73% of DTIL stock, in the hands of institutional investors. The top three institutional holders of DTIL stocks are: JANUS HENDERSON GROUP PLC with ownership of 0.63 million shares, which is approximately 9.0879%. TANG CAPITAL MANAGEMENT LLC, holding 0.62 million shares of the stock with an approximate value of $$6.07 million in DTIL stocks shares; and TANG CAPITAL MANAGEMENT LLC, currently with $$4.15 million in DTIL stock with ownership which is approximately 6.119%.
